Ketamine-polymer based drug delivery system for prolonged analgesia: recent advances, challenges and future prospects

References

• Meints SM, Edwards RR. Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:168–182.
   PubMed Web of Science ®Google Scholar
• Tawil S, Iskandar K, Salameh P. Pain management in hospitals: patients’ satisfaction and related barriers. Pharm Pract (Granada). 2018;16(3):1268.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Bazargan-Hejazi S, Zadie ZH, et al. Pain management in trauma: a review study. J Inj Violence Res. 2016;8(2):89–98.
   PubMedGoogle Scholar
• Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Dtsch Arztebl Int. 2016;113(37):616–626.
   PubMed Web of Science ®Google Scholar
• Cavalli E, Mammana S, Nicoletti F, et al. The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:205873841938383.
   Web of Science ®Google Scholar
• Sica A, Casale B, Dato MTD, et al. Cancer- and non-cancer related chronic pain: from the physiopathological basics to management. Open Med (Wars). 2019;14(1):761–766.
   PubMedGoogle Scholar
• Ripamonti CI, Bossi P, Santini D, et al. Pain related to cancer treatments and diagnostic procedures: a no man’s land? Ann Oncol. 2014;25(6):1097–1106.
   PubMed Web of Science ®Google Scholar
• Koop SMW, Ten Klooster PM, Vonkeman HE, et al. Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):237.
   PubMedGoogle Scholar
• Buckenmaier C, Griffith S. Military pain management in 21st century war. Mil Med. 2010;7(7S):7–12.
   Google Scholar
• Vallerand AH, Cosler P, Henningfield JE, et al. Pain management strategies and lessons from the military: a narrative review. Pain Res Manag. 2015;20(5):261–268.
   PubMed Web of Science ®Google Scholar
• Armenta RF, Rush T, LeardMann CA, et al. Factors associated with persistent posttraumatic stress disorder among U.S. military service members and veterans. BMC Psychiatry. 2018;18(1):48.
   PubMed Web of Science ®Google Scholar
• Duenas M, Ojeda B, Salazar A, et al. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016;9:457–467.
   PubMed Web of Science ®Google Scholar
• Wedmore IS, Butler JFK. Battlefield analgesia in tactical combat casualty care. Wilderness Environ Med. 2017;28(2):S109–116.
   PubMed Web of Science ®Google Scholar
• Maniar KH, Jones IA, Gopalakrishna R, et al. Lowering side effects of NSAID usage in osteoarthritis: recent Attempts at minimizing dosage. Expert Opin Pharmacother. 2018;19(2):93–102.
   PubMed Web of Science ®Google Scholar
• Scheiman JM. NSAID-induced Gastrointestinal Injury: a focused update for clinicians. J Clin Gastroenterol. 2016;50(1):5–10.
   PubMed Web of Science ®Google Scholar
• De Boer HD, Detriche O, Forget P. Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol. 2017;31(4):499–504.
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Mehta Z, Ahmed E. Prevention and management of side effects in patients receiving opioids for chronic pain. UpToDate. 2020.
   Google Scholar
• Grant M, Kwiatkowski A, Shakoor N, et al. The opioid epidemic: the rheumatology response to management of chronic pain [abstract]. Arthritis Rheumatol. 2019;71(suppl):10.
   Google Scholar
• Zamora-Legoff JA, Achenbach SJ, Crowson CS, et al. Opioid use in patients with rheumatoid arthritis 2005–2014: a population-based comparative study. Clin Rheumatol. 2016;35(5):1137–1144.
   PubMed Web of Science ®Google Scholar
• Creaky Joints GHFL [Internet]. New York: Barbara Brody; [cited 2019 Apr 3]. Available from: https://creakyjoints.org/treatment/opioid-use-in-rheumatoid-arthritis/
   Google Scholar
• Day AL, Curtis JR. Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices. CurrOpinRheumatol. 2019;31:264–270.
   Google Scholar
• Brooks JZ, Poague C, Formagini T, et al. Palliative care’s role managing cancer pain during the opioid crisis: a qualitative study of patients, caregivers, and clinicians. J Pain Symptom Manage. 2020 (In Press). ;60(6):1127–1135.e2.
   PubMed Web of Science ®Google Scholar
• Rosa WE, Riegel B, Ulrich CM, et al. A concept analysis of analgesic nonadherence for cancer pain in a time of opioid crisis. Nurs Outlook. 2020;68(1):83–93.
   PubMed Web of Science ®Google Scholar
• Wardhan R, Chelly J. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy Version 1. F1000Res. 2017;6:2065.
   PubMedGoogle Scholar
• Cuomo A, Bimonte S, Forte CA, et al. Multimodal approaches and tailored therapies for pain management: the trolley analgesic model. J Pain Res. 2019;12:711–714.
   PubMed Web of Science ®Google Scholar
• Moy R, Wright C. Ketamine for military prehospital analgesia and sedation in combat casualties. J R Army Med Corps. 2018;164(6):436–437.
   PubMed Web of Science ®Google Scholar
• Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8(3):283–290.
   PubMedGoogle Scholar
• Bowers KJ, McAllister KB, Ray M, et al. Ketamine as an adjunct to opioids for acute pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2017;24(6):676–685.
   PubMed Web of Science ®Google Scholar
• Abdollahpur A, Saffarieh E, Zoroufchi BH. A review on the recent application of ketamine in management of anesthesia, pain, and health care. J Family Med Prim Care. 2020;9(3):1317–1324.
   PubMedGoogle Scholar
• Bell RF, Kalso EA. Ketamine for pain management. Pain Rep. 2018;3(5):e674.
   PubMedGoogle Scholar
• Torres AC, Bebarta VS, April MD, et al. Ketamine administration in prehospital combat injured patients with traumatic brain injury: a 10-year report of survival. Cureus. 2020;12(7):e9248.
   PubMed Web of Science ®Google Scholar
• Rascón-Martínez DM, Carrillo-Torres O, Ramos-Natarenc RG, et al. Advantages of ketamine as a perioperative analgesic. Rev Med Hosp Gen Méx. 2016;81:253–261.
   Google Scholar
• Azevedo VMS, Lauretti GR. Transdermal ketamine as an adjuvant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockade. Anesth Analg. 2001;91:1472–1482.
   Web of Science ®Google Scholar
• Han FY, Whittaker AK, Howdle SM, et al. Formulation of bioerodible ketamine microparticles as an analgesic adjuvant treatment produced by supercritical fluid polymer encapsulation. Pharmaceutics. 10(4): 264. 2018.
   Web of Science ®Google Scholar
• Karvekar M, Khan AB. A brief review on sustained release matrix type drug delivery system. J Pharm Res. 2017;16(3):282.
   Google Scholar
• Mandhar P, Joshi G. Development of sustained release drug delivery system: a review. Asian Pac J Health Sci. 2015;2(1):179–185.
   Google Scholar
• Shepherd SD, O’Buckley SC, Harrington JM, et al. A moldable sustained release bupivacaine formulation for tailored treatment of postoperative dental pain. Sci Rep. 2018;8:(1):12172.
   PubMedGoogle Scholar
• Martin C, Baerdemaeker A, Poelaert J, et al. Controlled-release of opioids for improved pain management. Mater Today. 2016;19(9):491–502.
   Web of Science ®Google Scholar
• Motov S, Rockoff B, Cohen V, et al. Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial. Ann Emerg Med. 2015;66(3):222–229.
   PubMed Web of Science ®Google Scholar
• Losvik OK, Murad MK, Skjerve E, et al. Ketamine for prehospital trauma analgesia in a low-constrained rural trauma system: a retrospective comparative study of ketamine and opioid analgesia in a ten-year cohort in Iraq. Scand J Trauma Resusc Emerg Med. 2015;23(1):94.
   PubMedGoogle Scholar
• Shackelford SA, Fowler M, Schultz K, et al. Prehospital pain medication use by U.S. forces in Afghanistan. Mil Med. 2015;180(3):304–309.
   PubMed Web of Science ®Google Scholar
• Bronsky ES, Koola C, Orlando A, et al. Intravenous Low-dose ketamine provides greater pain control compared to fentanyl in a civilian prehospital trauma system: a propensity matched analysis. Prehosp Emerg Care. 2019;23(1):1–8.
   PubMed Web of Science ®Google Scholar
• Mahshidfar B, Mofidi M, Fattahi M, et al. Acute pain management in emergency department, low dose ketamine versus morphine, a randomized clinical trial. Anesth Pain Med. 2017;7(6):e60561.
   PubMedGoogle Scholar
• Karlow N, Schlaepfer CH, Stoll CRT, et al. A systematic review and meta-analysis of ketamine as an alternative to opioids for acute pain in the emergency department. Acad Emerg Med. 2018;10(10):1086–1097.
   Google Scholar
• Toftegregers MC, Mikkelsen S, Lindvig KP, et al. Ketamine as an anesthetic for patients with acute brain injury: a systematic review. Neurocrit Care. 2020;33(1):273–282.
   PubMed Web of Science ®Google Scholar
• Khodneva Y, Muntner P, Kertesz S, et al. Prescription opioid use and risk of coronary heart disease, stroke, and cardiovascular death among adults from a prospective cohort (REGARDS study). Pain Med. 2016;17(3):444–455.
   PubMed Web of Science ®Google Scholar
• Hinojosa-Laborde C, Calderon M, Crimmins S, et al. Effects of ketamine on cardiovascular and respiratory responses to traumatic hemorrhage in rats. The J Pain. 2018;19(3):S6–S7.
   Google Scholar
• Chan LC, Raty SR, Ortiz J, et al. The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries. CNS Neurosci Ther. 2013;19(6):390–395.
   PubMed Web of Science ®Google Scholar
• Hirano S, Bovi M, Romeo A, et al. Ketamine nano-delivery based on poly-lactic-co-glycolic acid (PLGA) nanoparticles. Appl Nanosci. 2018;8(4):655–663.
   Web of Science ®Google Scholar
• Sowjanya M, Debnath S, Thejovathi R, et al. Polymers used in the Designing of Controlled Drug Delivery System. Res J Pharm Tech. 2017;10(3):903–912.
   Google Scholar
• Malyan M, Becchi C, Nikkola L, et al. Polymer-based biodegradable drug delivery systems in pain management. J Craniofac Surg. 2006;17(2):302–313.
   PubMed Web of Science ®Google Scholar
• Shikanov A, Domb AJ, Weiniger CF. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. J Control Release. 2007;117(1):97–103.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy R, Torchilin VP Hydrogels and their applications in targeted drug delivery Molecules. 2019;24:603.
   Google Scholar
• Kamaly N, Yameen B, Wu J, et al. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602–2663.
   PubMed Web of Science ®Google Scholar
• Dawes GJS, Fratila-apachitei LE, Mulia K, et al. Size effect of PLGA spheres on drug loading efficiency and release profiles. J Mater Sci Mater Med. 2009;20(5):1089–1094.
   PubMed Web of Science ®Google Scholar
• Raval A, Parikh J, Engineer C. Mechanism of controlled release kinetics from medical devices. Braz J Chem Eng. 2010;27(2):211–225.
   Web of Science ®Google Scholar
• Liu M, Zheng X. Preparation and assessment of ketamine hydrogels for prolonged transdermal anaesthesia. Trop J Pharm Res. 2017;16(7):1481–1487.
   Web of Science ®Google Scholar
• Wang R, Gan J, Li R, et al. Controlled delivery of ketamine from reduced graphene oxide hydrogel for neuropathic pain: in vitro and in vivo studies. J Drug Deliv Sci Technol. 2020;60:101964.
   Web of Science ®Google Scholar
• Crowley KL, Flores JA, Hughes CN, et al. Clinical application of ketamine ointment in the treatment of sympathetically maintained pain. Int J Pharm Compd. 1998;2:122–127.
   PubMedGoogle Scholar
• He Y, Qin L, Huang Y, et al. Advances of nano-structures extended-release local anesthetics. Nanoscale Res Lett. 2020;15(1):15.
   PubMed Web of Science ®Google Scholar
• Han Y, Liu Y, Kumar V, et al. Sustained-release ketamine-loaded nanoparticles fabricated by sequential nanoprecipitation. Int J Pharm. 2020;581:119291.
   PubMedGoogle Scholar
• Highland JN, Morris PJ, Zanos P, et al. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine. J Psychopharmacol. 2019;33(1):12–24.
   PubMed Web of Science ®Google Scholar
• Toki H, Ichikawa T, Mizuno-Yasuhira A, et al. A rapid and sensitive chiral LC-MS/MS method for the determination of ketamine and norketamine in mouse plasma, brain and cerebrospinal fluid applicable to the stereoselective pharmacokinetic study of ketamine. J Pharm Biomed Anal. 2018;148:288–297.
   PubMed Web of Science ®Google Scholar
• Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomed. 2013;8:2997–3017.
   PubMed Web of Science ®Google Scholar
• Lee YH, Mei F, Bai MY, et al. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray. J Control Release. 2010;145(1):58–65.
   PubMed Web of Science ®Google Scholar
• Zhu M, Whittaker AK, Smith MT, et al., Bioerodable ketamine-loaded microparticles fabricated using dissolvable hydrogel template technology. J Pharm Sci. 108(3): 1220–1226. 2019.
   PubMed Web of Science ®Google Scholar
• Alkilani AZ, MTC M, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470.
   PubMed Web of Science ®Google Scholar
• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57(11):1595–1639.
   PubMed Web of Science ®Google Scholar
• Gammaitoni A, Gallager RM, Welz-Bosna M. Topical ketamine gel:Possible role in treating neuropathic pain. Pain Med. 2000;1(1):97–100.
   PubMed Web of Science ®Google Scholar
• Sawynok J. Topical and peripheral ketamine as an analgesic. AnesthAnalg. 2014;119:170–178.
   Google Scholar
• Cline AE, Turrentine JE. Compounded topical analgesics for chronic pain. Dermatitis. 2016;27(5):263–271.
   PubMed Web of Science ®Google Scholar
• Bassani AS, Banov D. Evaluation of the percutaneous absorption of ketamine hcl, gabapentin, clonidine hcl, and baclofen, in compounded transdermal pain formulations, using the Franz finite dose model. Pain Med. 2016;17(2):230–238.
   PubMed Web of Science ®Google Scholar
• Flores JA, Crowley KL, Process for the preparation of ketamine ointment, US5817699A, 1998.
   Google Scholar
• Boudy V, Tibi A, D’Hayer B, et al., Gelling formulation containing ketamine, US20150224070A1, 2014.
   Google Scholar
• NIH Clinical Trials.gov [Internet]. Pain relief unit and anaesthesiology, university Hospital Basel, switzerland: Clinical Trials.gov; [cited 2018 Nov 13]. Available From: https://clinicaltrials.gov/ct2/show/NCT02591017.
   Google Scholar
• Ford PR, Topical pain relief composition and carrier, US6461600B1, 2002.
   Google Scholar
• Nivorozhkin A, Landrau N, Single-layer oral dose of neuro-attenuating ketamine WO2015031410A1, 2015.
   Google Scholar
• Nivorozhkin A, Landrau N, Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods, WO2015031410A1, 2016.
   Google Scholar
• Tang H, Hock ST, Mayersohn M, Transdermal drug delivery system for ketamine, US20200030251, 2020.
   Google Scholar
• Shah SA, Sohail M, Khan S, et al. Biopolymer-based biomaterials for accelerated diabetic wound healing: a critical review. Int J Biol Macromol. 2019;139:975–993.
   PubMed Web of Science ®Google Scholar
• Kubo W, Konno Y, Miyazaki S, et al. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Ind Pharm. 2004;30:593–599.
   PubMed Web of Science ®Google Scholar
• Kianfar F, Antonijevic M, Chowdhry B, et al. Formulation development of a carrageenan based delivery system for buccal drug delivery using ibuprofen as a model drug. J Biomater Nanobiotechnol. 2011;2(5):582–595.
   Google Scholar
• Li J, Yao P. Self-assembly of ibuprofen and bovine serum albumin−dextran conjugates leading to effective loading of the drug. Langmuir. 2009;25(11):6385–6391.
   PubMed Web of Science ®Google Scholar
• Ioan DC, Rau I, Tihan GT, et al. Piroxicam-Collagen based sponges for medical applications. Int J Polym Sci. 2019;2019:7.
   Web of Science ®Google Scholar
• Tihan GT, Rau I, Zgarian RG, et al. Collagen based biomaterials for ibuprofen delivery. C R Chim. 2016;19(3):390–394.
   Web of Science ®Google Scholar
• Stoicea N, Fiorda-Diaz J, Joseph N, et al. Advanced analgesic drug delivery and nanobiotechnology. Drugs. 2017;77(10):1069–1076.
   PubMed Web of Science ®Google Scholar
• Basha M, Abd El-Alim SH, Kassem AA, et al. Benzocaine loaded solid lipid nanoparticles: formulation design, in vitro and in vivo evaluation of local anesthetic effect. Curr Drug Deliv. 2015;12(6):680–692.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Man N, Xu T, et al. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci. 2007;96(3):595–602.
   PubMed Web of Science ®Google Scholar
• Kao CW, Lee D, Wu M, et al. Lidocaine/ketorolac-loaded biodegradable nanofibrous anti-adhesive membranes that offer sustained pain relief for surgical wounds. Int J Nanomedicine. 2017;12:5893–5901.
   PubMed Web of Science ®Google Scholar
• Moriarty O, Ruane N, O’Gorman D, et al. Cognitive impairment in patients with chronic neuropathic or radicular pain: an interaction of pain and age. Front Behav Neurosci. 2017;11:100.
   PubMed Web of Science ®Google Scholar
• Couette M, Mouchabac S, Bourla A, et al. Social cognition in post-traumatic stress disorder: a systematic review. Br J Clin Psychol. 2019;59(2):117–138.
   PubMed Web of Science ®Google Scholar